Synthetic dendrimeric peptide active against biofilm and persister cells of Pseudomonas aeruginosa

Applied Microbiology and Biotechnology

Volumn 99, Issue 19, 2015, Pages 8125-8135

  Bahar, Ali Adem ^a,b   Liu, Zhigang ^c   Totsingan, Filbert ^c   Buitrago, Carlos ^c   Kallenbach, Neville ^c   Ren, Dacheng ^a,b  

^a Syracuse University   (United States)

^b SYRACUSE UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Antimicrobial peptide; Biofilm; Killing; Persister cells; Pseudomonas aeruginosa

Indexed keywords

AMINO ACIDS; ANTIBIOTICS; ANTIMICROBIAL AGENTS; BACTERIA; BIOFILMS; BLOOD; CELLS; FUNCTIONAL GROUPS; MAMMALS; MICROORGANISMS; PEPTIDES;

ANTI-MICROBIAL ACTIVITY; ANTIMICROBIAL PEPTIDE; DOSE-DEPENDENT MANNER; HUMAN EPITHELIAL CELLS; KILLING; MULTIVALENT STRUCTURES; PERSISTER CELLS; PSEUDOMONAS AERUGINOSA;

CYTOLOGY;

ANTIMICROBIAL DENDRIMERIC PEPTIDE 2D 24; ARGININE; CARBENICILLIN; CIPROFLOXACIN; POLYPEPTIDE ANTIBIOTIC AGENT; TOBRAMYCIN; TRYPTOPHAN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; PEPTIDE;

ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOFILM; BLOOD; CELLS AND CELL COMPONENTS; CONCENTRATION (COMPOSITION); DOSE-RESPONSE RELATIONSHIP; FUNCTIONAL GROUP; PEPTIDE; PERSISTENCE; SHEEP;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOFILM; COCULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; DRUG SAFETY; EPITHELIUM CELL; HEMOLYSIS; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; PSEUDOMONAS AERUGINOSA; SHEEP ERYTHROCYTE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY; SYNTHESIS;

MAMMALIA; OVIS ARIES; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BIOFILMS; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; PEPTIDES; PSEUDOMONAS AERUGINOSA;

EID: 84941183543     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-015-6645-7     Document Type: Article

References (59)

1. Alhoot MA, Rathinam AK, Wang SM, Manikam R, Sekaran SD (2013) Inhibition of dengue virus entry into target cells using synthetic antiviral peptides. Int J Med Sci 10:719–729
2. Andersson C, Al-Turkmani MR, Savaille JE, Alturkmani R, Katrangi W, Cluette-Brown JE, Zaman MM, Laposata M, Freedman SD (2008) Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolism. J Lipid Res 49:1692–1700
3. Arrighi RB, Nakamura C, Miyake J, Hurd H, Burgess JG (2002) Design and activity of antimicrobial peptides against sporogonic-stage parasites causing murine malarias. Antimicrob Agents Chemother 46:2104–2110
4. Bahar AA, Ren D (2013) Antimicrobial peptides. Pharmaceuticals 6:1543–1575
5. Bodey GP, Bolivar R, Fainstein V, Jadeja L (1983) Infections caused by Pseudomonas aeruginosa. Rev Infect Dis 5:279–313
6. Butler K, English AR, Ray VA, Timreck AE (1970) Carbenicillin: chemistry and mode of action. J Infect Dis 122(Suppl):S1–S8
7. Chen X, Zhang M, Zhou CH, Kallenbach NR, Ren DC (2011) Control of bacterial persister cells by Trp/Arg-containing antimicrobial peptides. Appl Environ Microbiol 77:4878–4885
8. Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, Dasgupta M, Marrie TJ (1987) Bacterial biofilms in nature and disease. Annu Rev Microbiol 41:435–464
9. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322
10. de Bentzmann S, Plesiat P (2011) The Pseudomonas aeruginosa opportunistic pathogen and human infections. Environ Microbiol 13:1655–1665
11. DeVries CA, Ohman DE (1994) Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation. J Bacteriol 176:6677–6687
12. Drlica K, Zhao X (1997) DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 61:377–392
13. Flemming HC, Wingender J (2010) The biofilm matrix. Nat Rev Microbiol 8:623–633
14. Gilbert P, Das J, Foley I (1997) Biofilm susceptibility to antimicrobials. Adv Dent Res 11:160–167
15. Hall-Stoodley L, Costerton JW, Stoodley P (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2:95–108
16. Hancock REW, Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24:1551–1557
17. Haug BE, Stensen W, Kalaaji M, Rekdal O, Svendsen JS (2008) Synthetic antimicrobial peptidomimetics with therapeutic potential. J Med Chem 51:4306–4314
18. He J, Eckert R, Pharm T, Simanian MD, Hu CH, Yarbrough DK, Qi FX, Anderson MH, Shi WY (2007) Novel synthetic antimicrobial peptides against Streptococcus mutans. Antimicrob Agents Chemother 51:1351–1358
19. Hengzhuang W, Wu H, Ciofu O, Song Z, Hoiby N (2011) Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 55:4469–4474
20. Hentzer M, Teitzel GM, Balzer GJ, Heydorn A, Molin S, Givskov M, Parsek MR (2001) Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J Bacteriol 183:5395–5401
21. Hou SY, Zhou CH, Liu ZG, Young AW, Shi ZH, Ren DC, Kallenbach NR (2009) Antimicrobial dendrimer active against Escherichia coli biofilms. Bioorg Med Chem Lett 19:5478–5481
22. Hou SY, Liu ZG, Young AW, Mark SL, Kallenbach NR, Ren DC (2010) Effects of Trp- and Arg-containing antimicrobial-peptide structure on inhibition of Escherichia coli planktonic growth and biofilm formation. Appl Environ Microbiol 76:1967–1974
23. Huang HW (2006) Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim Biophys Acta 1758:1292–1302
24. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K (2004) Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 186:8172–8180
25. Kim JY, Park SC, Yoon MY, Hahm KS, Park Y (2011) C-terminal amidation of PMAP-23: translocation to the inner membrane of Gram-negative bacteria. Amino Acids 40:183–195
26. Kint CI, Verstraeten N, Fauvart M, Michiels J (2012) New found fundamentals of bacterial persistence. Trends Microbiol 20:577–585
27. Lam J, Chan R, Lam K, Costerton JW (1980) Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 28:546–556
28. Le Goffic F, Capmau ML, Tangy F, Baillarge M (1979) Mechanism of action of aminoglycoside antibiotics. Binding studies of tobramycin and its 6′-N-acetyl derivative to the bacterial ribosome and its subunits. Eur J Biochem 102:73–81
29. Lee DG, Hahm KS, Shin SY (2004) Structure and fungicidal activity of a synthetic antimicrobial peptide, P18, and its truncated peptides. Biotechnol Lett 26:337–341
30. Lewis K (2007) Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5:48–56
31. Lewis K (2010) Persister cells. Annu Rev Microbiol 64:357–372
32. Lewis K (2013) Platforms for antibiotic discovery. Nat Rev Drug Discov 12:371–387
33. Liu ZG, Young AW, Hu P, Rice AJ, Zhou CH, Zhan YK, Kallenbach NR (2007) Tuning the membrane selectivity of antimicrobial peptides by using multivalent design. Chembiochem 8:2063–2065
34. Lowbury EJL, Kidson A, Lilly HA, Ayliffe GAJ (1969) Sensitivity of Pseudomonas aeruginosa to antibiotics—emergence of strains highly resistant to carbenicillin. Lancet 2:448–452
35. Ma L, Conover M, Lu H, Parsek MR, Bayles K, Wozniak DJ (2009) Assembly and development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathog 5:e1000354
36. Mah TF, O'Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9:34–39
37. Marchand C, Krajewski K, Lee HF, Antony S, Johnson AA, Amin R, Roller P, Kvaratskhelia M, Pommier Y (2006) Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites. Nucleic Acids Res 34:5157–5165
38. Martin E, Ganz T, Lehrer RI (1995) Defensins and other endogenous peptide antibiotics of vertebrates. J Leukoc Biol 58:128–136
39. Mathee K, Ciofu O, Sternberg C, Lindum PW, Campbell JI, Jensen P, Johnsen AH, Givskov M, Ohman DE, Molin S, Hoiby N, Kharazmi A (1999) Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 145:1349–1357
40. McDougald D, Rice SA, Barraud N, Steinberg PD, Kjelleberg S (2012) Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal. Nat Rev Microbiol 10:39–50
41. Mulcahy LR, Burns JL, Lory S, Lewis K (2010) Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol 192:6191–6199
42. Naghmouchi K, Le Lay C, Baah J, Drider D (2012) Antibiotic and antimicrobial peptide combinations: synergistic inhibition of Pseudomonas fluorescens and antibiotic-resistant variants. Res Microbiol 163:101–108
43. Niepa TH, Gilbert JL, Ren D (2012) Controlling Pseudomonas aeruginosa persister cells by weak electrochemical currents and synergistic effects with tobramycin. Biomaterials 33:7356–7365
44. Noto PB, Abbadessa G, Cassone M, Mateo GD, Agelan A, Wade JD, Szabo D, Kocsis B, Nagy K, Rozgonyi F, Otvos L Jr (2008) Alternative stabilities of a proline-rich antibacterial peptide in vitro and in vivo. Protein Sci 17:1249–1255
45. Ojha AK, Baughn AD, Sambandan D, Hsu T, Trivelli X, Guerardel Y, Alahari A, Kremer L, Jacobs WR Jr, Hatfull GF (2008) Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol Microbiol 69:164–174
46. Olson ME, Ceri H, Morck DW, Buret AG, Read RR (2002) Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res 66:86–92
47. Pan J, Bahar AA, Syed H, Ren D (2012) Reverting antibiotic tolerance of Pseudomonas aeruginosa PAO1 persister cells by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one. PLoS One 7:e45778
48. Powell WA, Catranis CM, Maynard CA (1995) Synthetic antimicrobial peptide design. Mol Plant Microbe Interact 8:792–794
49. Pritt B, O'Brien L, Winn W (2007) Mucoid Pseudomonas in cystic fibrosis. Am J Clin Pathol 128:32–34
50. Romero R, Schaudinn C, Kusanovic JP, Gorur A, Gotsch F, Webster P, Nhan-Chang CL, Erez O, Kim CJ, Espinoza J, Goncalves LF, Vaisbuch E, Mazaki-Tovi S, Hassan SS, Costerton JW (2008) Detection of a microbial biofilm in intraamniotic infection. Am J Obstet Gynecol 198(135):e131–e135
51. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
52. Schmidt NW, Deshayes S, Hawker S, Blacker A, Kasko AM, Wong GC (2014) Engineering persister-specific antibiotics with synergistic antimicrobial functions. ACS Nano 8:8786–8793
53. Schurr MJ, Yu H, Martinez-Salazar JM, Boucher JC, Deretic V (1996) Control of AlgU, a member of the sigma E-like family of stress sigma factors, by the negative regulators MucA and MucB and Pseudomonas aeruginosa conversion to mucoidy in cystic fibrosis. J Bacteriol 178:4997–5004
54. Tam JP, Lu YA, Yang JL (2002) Antimicrobial dendrimeric peptides. Eur J Biochem 269:923–932
55. Uteng M, Hauge HH, Markwick PRL, Fimland G, Mantzilas D, Nissen-Meyer J, Muhle-Goll C (2003) Three-dimensional structure in lipid micelles of the pediocin-like antimicrobial peptide sakacin P and a sakacin P variant that is structurally stabilized by an inserted C-terminal disulfide bridges. Biochemistry 42:11417–11426
56. Wang G, Li X, Wang Z (2009) APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res 37:D933–D937
57. Winsor GL, Lam DK, Fleming L, Lo R, Whiteside MD, Yu NY, Hancock RE, Brinkman FS (2011) Pseudomonas genome database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res 39:D596–D600
58. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389–395
59. Zhao X, Wu H, Lu H, Li G, Huang Q (2013) LAMP: a database linking antimicrobial peptides. PLoS One 8:e66557